These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 5351802)

  • 21. Four years' experience with dapsone as prophylaxis against leprosy.
    Otsyula Y; Ibworo C; Chum HJ
    Lepr Rev; 1971 Jun; 42(2):98-100. PubMed ID: 5150032
    [No Abstract]   [Full Text] [Related]  

  • 22. Influence of once-monthly rifampicin and daily clofazimine on the pharmacokinetics of dapsone in leprosy patients in Nigeria.
    Pieters FA; Woonink F; Zuidema J
    Eur J Clin Pharmacol; 1988; 34(1):73-6. PubMed ID: 3360051
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Trials of preventive therapy.
    Blanc LJ
    Int J Lepr Other Mycobact Dis; 1999 Dec; 67(4 Suppl):S7-9. PubMed ID: 10700928
    [No Abstract]   [Full Text] [Related]  

  • 24. Leprosy--a complementary contribution.
    Trop Doct; 1973 Jul; 3(3):97-8. PubMed ID: 4736659
    [No Abstract]   [Full Text] [Related]  

  • 25. Recent changes in leprosy control.
    Sansarricq H
    Lepr Rev; 1983 Jun; Spec No():7-16. PubMed ID: 6350774
    [No Abstract]   [Full Text] [Related]  

  • 26. Leprosy in children and its impact on community health.
    Hazra SK; Ghosh S
    Indian J Dermatol; 1981 Jan; 26(1):1-7. PubMed ID: 7347315
    [No Abstract]   [Full Text] [Related]  

  • 27. Problems of leprosy relapse in China.
    Li HY
    Int J Lepr Other Mycobact Dis; 1993 Mar; 61(1):1-7. PubMed ID: 8326169
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Editorial: Prevention of leprosy.
    J Trop Med Hyg; 1974 Mar; 77(3):49. PubMed ID: 4598138
    [No Abstract]   [Full Text] [Related]  

  • 29. Erythema nodosum leprosum in Nigeria.
    Somorin AO
    Int J Dermatol; 1975 Nov; 14(9):664-6. PubMed ID: 1184260
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [The anti-leprosy campaign in Vietnam. Integration at the primary health care level].
    Lê KD
    Acta Leprol; 1982; (86-87):23-7. PubMed ID: 6815992
    [No Abstract]   [Full Text] [Related]  

  • 31. Prevalence of secondary dapsone resistance in Gudiyattam Taluk, the leprosy control area of the Schieffelin Leprosy Research and Training Centre, Karigiri. 1. Preliminary report.
    Balraj V; Jesudasan K; Chacko CJ; Christian M; Taylor PM; Fritschi EP; Job CK
    Int J Lepr Other Mycobact Dis; 1980 Dec; 48(4):397-401. PubMed ID: 7193654
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Leprosy at a turning point?
    Harboe M
    Int J Lepr Other Mycobact Dis; 2000 Sep; 68(3):312-8. PubMed ID: 11221095
    [No Abstract]   [Full Text] [Related]  

  • 33. Organizing a leprosy control programme.
    Browne SG
    Trop Doct; 1979 Apr; 9(2):93-6. PubMed ID: 473377
    [No Abstract]   [Full Text] [Related]  

  • 34. Antileprosy measures in Bombay, India: an analysis of 10 years' work.
    Koticha KK; Nair PR
    Bull World Health Organ; 1976; 54(1):67-77. PubMed ID: 827341
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Evaluation of leprosy mass screening campaign in Upper Volta after 10 years of activities (1966-1976)].
    Blanc M
    Acta Leprol; 1978; (73):39-58. PubMed ID: 108912
    [No Abstract]   [Full Text] [Related]  

  • 36. LEPROSY CONTROL METHODS.
    BUKER RS
    JAMA; 1965 Aug; 193():643-5. PubMed ID: 14321529
    [No Abstract]   [Full Text] [Related]  

  • 37. Methods of leprosy prevention.
    Crawford CL
    Nature; 1990 May; 345(6274):392. PubMed ID: 2342571
    [No Abstract]   [Full Text] [Related]  

  • 38. Infectivity of secondary dapsone-resistant cases.
    Jesudasan K; Pannikar V; Christian M
    Int J Lepr Other Mycobact Dis; 1988 Sep; 56(3):418-21. PubMed ID: 3047282
    [TBL] [Abstract][Full Text] [Related]  

  • 39. WHO expert committee on leprosy.
    World Health Organ Tech Rep Ser; 1970; 459():3-31. PubMed ID: 4993944
    [No Abstract]   [Full Text] [Related]  

  • 40. NLEP--current situation and strategy during the 11th plan period (2007-2012).
    Dhillon GP
    J Indian Med Assoc; 2006 Dec; 104(12):671-2. PubMed ID: 17474280
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.